Filters close
Newswise: New Case Western Reserve University study finds diabetes drug may reduce risk for colorectal cancer
5-Dec-2023 11:05 AM EST
New Case Western Reserve University study finds diabetes drug may reduce risk for colorectal cancer
Case Western Reserve University

A groundbreaking study by researchers at Case Western Reserve University suggests a class of medications used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC).

Released: 6-Dec-2023 2:05 PM EST
Could anti-obesity medications affect survival in people with knee or hip osteoarthritis?
Wiley

New research published in Arthritis & Rheumatology suggests that for people overweight or with obesity who also have knee or hip osteoarthritis, a slow-to-moderate—but not fast—rate of weight loss caused by anti-obesity medications may lower their risk of premature death.

Released: 6-Dec-2023 8:05 AM EST
Cleveland Clinic Study Identifies Factors Associated With Long-Term Use of FDA-Approved Anti-Obesity Medications
Cleveland Clinic

A Cleveland Clinic study looked at the long-term use of anti-obesity medications and found that only 19% of the study participants continued to use the medications one year after their initial prescriptions.

Released: 29-Nov-2023 1:05 PM EST
Non-Europeans have more eating disorder symptoms - but are less likely to receive specialist treatment
Karolinska Institute

People in Sweden of non-European descent have almost three times as many eating disorder symptoms as people born in Sweden. But despite this, they have significantly less access to specialist treatment. This is according to new research from Karolinska Institutet published in BJPsych Open.

Newswise: VUMC receives $10 million to study childhood obesity interventions in rural and minority communities in Tennessee and Louisiana
Released: 29-Nov-2023 11:05 AM EST
VUMC receives $10 million to study childhood obesity interventions in rural and minority communities in Tennessee and Louisiana
Vanderbilt University Medical Center

  Vanderbilt University Medical Center has received a $10 million, five-year research funding award from the Patient-Centered Outcomes Research Institute (PCORI) to study the ideal “dose” of behavioral interventions to treat childhood obesity in rural and minority communities across Tennessee and Louisiana. Bill Heerman, MD, MPH, chief of the Division of General Pediatrics a Vanderbilt, will lead the randomized, multisite trial with co-principal investigator Amanda Staiano, PhD, at Louisiana State University’s Pennington Biomedical Research Center.

Released: 22-Nov-2023 8:05 AM EST
Mice eating less of specific amino acid — overrepresented in diet of obese people — live longer, healthier
University of Wisconsin–Madison

There’s a popular saying in some circles that “a calorie is a calorie,” but science shows that it may not be true. In fact, it may be possible to eat more of some kinds of calories while also improving your health.“We like to say a calorie is not just a calorie,” says Dudley Lamming, a professor and metabolism researcher at the University of Wisconsin School of Medicine and Public Health.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Not for public release

This news release is embargoed until 20-Nov-2023 5:00 PM EST Released to reporters: 14-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 20-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 20-Nov-2023 3:05 PM EST
C-sections in Mexico increase with obesity level and health care specialization
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

A new study from the University of Illinois Urbana-Champaign investigates how high obesity levels lead to hospital specializations that affect the frequency of C-sections in Mexico.

Released: 18-Nov-2023 1:05 PM EST
Benefits of adolescent fitness to future cardiovascular health possibly overestimated
Karolinska Institute

There is a well-known relationship between good physical fitness at a young age and a lower risk of cardiovascular disease later in life.

Released: 15-Nov-2023 11:20 AM EST
From Farm to Newsroom: The Latest Research and Features on Agriculture
Newswise

The world’s total population is expected to reach 9.9 billion by 2050. This rapid increase in population is boosting the demand for agriculture to cater for the increased demand. Below are some of the latest research and features on agriculture and farming in the Agriculture channel on Newswise.

Newswise: FDA approval for Zepbound: FSU researcher available for context on newly approved weight loss treatment
Released: 14-Nov-2023 3:05 PM EST
FDA approval for Zepbound: FSU researcher available for context on newly approved weight loss treatment
Florida State University

By: Bill Wellock | Published: November 14, 2023 | 2:43 pm | SHARE: The U.S. Food and Drug Administration recently approved the medication Zepbound for weight management treatment.Tirzepatide, the active ingredient in the Eli Lilly and Company’s trademarked Zepbound, was already approved to help improve blood sugar (glucose) in adults with type 2 diabetes mellitus.

13-Nov-2023 10:05 AM EST
New York State Dooms Diabetes Sufferers to Amputations, Dialysis and Alzheimers by Cutting Funds for Proven Programs That Help Residents Lower Blood Sugar Levels
Health People

Expressing outrage over the state’s plan to kill programs well-proven to slash diabetes and other chronic disease, activists, providers and patients rallied outside the state Health Department in lower Manhattan today, World Diabetes Day, to protest state negligence that will clearly impose even worse chronic disease on low-income communities already reeling from the aftermath of Covid-19.

   
Released: 12-Nov-2023 1:05 PM EST
HSS Research Shows Obesity Is Associated with Worse Flare Symptoms and Quality of Life in People with Early Rheumatoid Arthritis
Hospital for Special Surgery

Obesity is correlated with more severe disease flare symptoms and poorer outcomes in patients with early rheumatoid arthritis.

Newswise: Obesity linked to neurodegeneration through insulin resistance
31-Oct-2023 5:05 PM EDT
Obesity linked to neurodegeneration through insulin resistance
PLOS

Researchers led by Mroj Alassaf at the Fred Hutchinson Cancer Research Center in the United States have discovered a link between obesity and neurodegenerative disorders like Alzheimer’s disease.

Newswise: Study Suggests Body Mass Index Isn’t Obstacle to Chest Masculinization Surgery Eligibility
Released: 7-Nov-2023 9:30 AM EST
Study Suggests Body Mass Index Isn’t Obstacle to Chest Masculinization Surgery Eligibility
Johns Hopkins Medicine

In what is believed to be the largest study of the association between BMI and postoperative complications following chest masculinization surgery, researchers at the Johns Hopkins Center for Transgender and Gender Expansive Health provide evidence that BMI is a poor metric for determining who should be approved for the gender transitioning procedure.

Not for public release

This news release is embargoed until 6-Nov-2023 5:00 PM EST Released to reporters: 31-Oct-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Could fitness tests do more harm than good for Aussie kids?
Released: 5-Nov-2023 7:05 PM EST
Could fitness tests do more harm than good for Aussie kids?
University of South Australia

Beep test or shuttle run - we all remember fitness time trials in school. But did you know that your early experiences of compulsory fitness may have influenced your current views of physical exercise (PE)?

Newswise: What happens when cats get fat? Scientists weigh in
Released: 1-Nov-2023 2:05 PM EDT
What happens when cats get fat? Scientists weigh in
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

Feline obesity is on the rise, impacting the health, longevity, and wellbeing of cats. A new study from the University of Illinois Urbana-Champaign looks at what happens in the digestive system and gut microbiota when cats eat too much.

Released: 1-Nov-2023 1:05 PM EDT
Epigenetic signature for obesity found in study of twins
Washington State University

WSU study finds epigenetic signature in cheek cells of obese people, suggesting a biomarker test for obesity could be developed

Released: 1-Nov-2023 12:05 PM EDT
Wake Forest University School of Medicine Launches $100 Million Philanthropic Campaign for Research
Wake Forest University School of Medicine

Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist, the academic core of Advocate Health, are launching their largest campaign for research. Designed with health equity at the forefront, funds raised in this campaign will transform health care for patients, communities and the next generation of health care leaders by integrating research with clinical care while enhancing the speed with which new ideas move from research labs to patients' bedsides and beyond.

Released: 1-Nov-2023 10:05 AM EDT
Mayo Clinic Healthcare expert shares good news and bad news about angina
Mayo Clinic

Angina, chest discomfort caused by reduced blood flow to the heart, is a common symptom of coronary artery disease. There is good news and bad news, explains Stephen Brecker, M.D., a cardiologist at Mayo Clinic Healthcare in London.

Newswise: New hope to treat and reverse osteoarthritis
30-Oct-2023 11:55 PM EDT
New hope to treat and reverse osteoarthritis
University of Adelaide

Current osteoarthritis treatment manages symptoms rather than addressing the underlying disease, but a new University of Adelaide study has shown the condition may be treatable and reversible.

Released: 27-Oct-2023 5:05 PM EDT
Study: Metformin can help youth manage weight gain side effect of bipolar medications
University of Cincinnati

A new large-scale study led by researchers at the University of Cincinnati and Northwell Health, New York's largest health care provider, found the drug metformin can help prevent or reduce weight gain in youth taking medication to treat bipolar disorder.

Newswise: IU scientists part of NIH-funded national consortium focused on improving Alzheimer’s disease diagnoses
Released: 27-Oct-2023 11:05 AM EDT
IU scientists part of NIH-funded national consortium focused on improving Alzheimer’s disease diagnoses
Indiana University

Researchers at Indiana University School of Medicine will play key roles in a national consortium led by Wake Forest University School of Medicine to study the use, interpretation and implementation of biomarkers to diagnose Alzheimer's disease. The multi-institution effort is funded by a five-year, $9 million grant from the National Institute on Aging, part of the National Institutes of Health, that will establish the Alzheimer's Diagnosis in Older Adults with Chronic Conditions (ADACC) Network.

25-Oct-2023 11:00 AM EDT
Intermittent fasting is safe, effective for those with Type 2 diabetes
University of Illinois Chicago

More weight lost among people who fasted, compared to calorie restriction

Released: 26-Oct-2023 10:05 AM EDT
New guide details menopause’s effects on the workplace, other surprising impacts
University of Virginia Health System

A sweeping new guide to menopause by a UVA Health expert and collaborators highlights the profound and sometimes surprising effects the “change of life” can have on women’s lives, health, workplaces and even finances

Released: 26-Oct-2023 9:00 AM EDT
Virtual Science Writers Conference will examine obesity treatments and heart health
Endocrine Society

Endocrine Society experts will discuss how these medications and bariatric surgery can treat obesity and improve cardiometabolic health, during the Society’s Virtual Science Writers Conference on November 9.

Released: 24-Oct-2023 1:30 PM EDT
Expert anesthesiologist provides guidance for perioperative care of patients on GLP-1RA therapy
Wolters Kluwer Health: Lippincott

Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are successful in treating type 2 diabetes mellitus and obesity. However, their use can increase the risk of regurgitation and pulmonary aspiration of gastric contents during sedation or general anesthesia. In the January 2024 issue of Anesthesia & Analgesia, Girish P. Joshi, MBBS, MD, FFARCSI, Professor of Anesthesiology and Pain Management at the University of Texas Southwestern Medical Center in Dallas, shares clinical pearls for anesthesiologists providing perioperative care to patients using these drugs. Anesthesia & Analgesia, the official journal of the International Anesthesia Research Society, is published in the Lippincott portfolio by Wolters Kluwer.

19-Oct-2023 10:05 AM EDT
High Pregnancy Weight Gain Tied to Higher Risk of Later Death
Perelman School of Medicine at the University of Pennsylvania

Findings from 50 years of data highlighted the health risks when more weight is gained in pregnancy than recommended, especially when it comes to heart disease- and diabetes-related mortality

Released: 19-Oct-2023 2:05 PM EDT
UC Irvine study reveals surge in use of weight loss-linked drugs in California health system
University of California, Irvine

In a first-of-its-kind study, researchers from the University of California, Irvine have discovered an extraordinary surge in the utilization of weight loss-associated GLP-1 receptor agonists, a class of medications commonly used in the treatment of Type 2 diabetes and obesity, that is poised to accelerate, based on emerging clinical evidence.

Released: 18-Oct-2023 10:05 AM EDT
Aston University research identifies four eating behavior patterns in children
Aston University

Children fall broadly into four eating categories, according to new research at Aston University, and parents feed their children differently depending on those categories.

Newswise: Fred Hutch announces eight recipients of 2023 Dr. Eddie Méndez Scholar Award
Released: 17-Oct-2023 2:05 PM EDT
Fred Hutch announces eight recipients of 2023 Dr. Eddie Méndez Scholar Award
Fred Hutchinson Cancer Center

SEATTLE – OCTOBER 17, 2023 – Fred Hutchinson Cancer Center has announced the recipients of the 2023 Dr. Eddie Méndez Scholar Award, which recognizes early-career underrepresented minority scientists and scientists with disabilities.

Newswise: Broken mitochondria are guilty of obesity
Released: 17-Oct-2023 7:05 AM EDT
Broken mitochondria are guilty of obesity
Scientific Project Lomonosov

Scientists from Immanuel Kant Baltic Federal University on the base of literary sources have described in detail the connection between intracellular processes in mitochondria and metabolic disorders in human’s organism that lead to obesity and cardiovascular diseases.

10-Oct-2023 9:00 AM EDT
Children with prediabetes and obesity may be more likely to progress to diabetes
Endocrine Society

A new Journal of the Endocrine Society study highlights how to identify children at high risk of developing type 2 diabetes and strategies for prevention, such as anti-obesity or anti-diabetes medication and lifestyle changes.

Released: 11-Oct-2023 8:05 AM EDT
Maternal obesity predicts heart disease risk better than pregnancy complications
Northwestern University

Pregnancy complications such as preeclampsia and gestational diabetes have recently been associated with a higher risk of developing heart disease later in life. But a new Northwestern Medicine study has found obesity before or during pregnancy is the actual root cause of future cardiovascular disease.

Newswise:Video Embedded metformin-cuts-insulin-resistance-and-chances-of-kidney-disease-in-young-obese-rats
VIDEO
Released: 11-Oct-2023 7:00 AM EDT
Metformin Cuts Insulin Resistance and Chances of Kidney Disease in Young, Obese Rats
American Physiological Society (APS)

Improving insulin resistance with metformin, a medication used to treat Type 2 diabetes, reduced the chances of developing kidney disease in a prepubescent obese rat model, according to a new study from the University of Mississippi Medical Center.

Released: 9-Oct-2023 6:05 PM EDT
Heart disease risk, prevention and management redefined
American Heart Association (AHA)

Health experts are redefining cardiovascular disease (CVD) risk, prevention and management, according to a new American Heart Association presidential advisory published today in the Association’s flagship journal Circulation.

Newswise: More study needed into the ‘why’ of new weight-loss drugs
Released: 6-Oct-2023 1:05 PM EDT
More study needed into the ‘why’ of new weight-loss drugs
University of Washington School of Medicine

These drugs are not the be-all and end-all to weight-loss therapy, wrote Dr. Michael Schwartz in a commentary published Oct. 2 in The Journal of Clinical Investigation. His co-author was Sophie Yang Gou, a postdoctoral fellow in Schwartz’s lab at the University of Washington School of Medicine. Many experts seem to be saying “OK, we’ve fixed this problem. We’re done,” noted Schwartz, who co-directs the UW Medicine Diabetes Institute. That is simply not the case, he said.

3-Oct-2023 1:05 PM EDT
A UCLA-led team may have found the key to stimulating human brown adipose tissue into combating obesity
University of California, Los Angeles (UCLA), Health Sciences

A UCLA-led team of researchers has found nerve pathways that supply brown adipose tissue (BAT), a type of tissue that releases chemical energy from fat metabolism as heat – a finding that could pave the way toward using it to treat obesity and related metabolic conditions.

Newswise: UAH Nursing researcher to study cardiometabolic disease among Black women in the Deep South
Released: 3-Oct-2023 3:05 PM EDT
UAH Nursing researcher to study cardiometabolic disease among Black women in the Deep South
University of Alabama Huntsville

A researcher at The University of Alabama in Huntsville (UAH) has been awarded a $179,000 subcontract to explore community-based strategies for reducing high-burden chronic disease like obesity, diabetes, heart disease and cancer as part of an overall award totaling $4.2 million.

28-Sep-2023 1:05 PM EDT
Discrimination alters brain-gut ‘crosstalk,’ prompting poor food choices and increased health risks
University of California, Los Angeles (UCLA), Health Sciences

People frequently exposed to racial or ethnic discrimination may be more susceptible to obesity and related health risks in part because of a stress response that changes biological processes and how we process food cues according to UCLA research.

Not for public release

This news release is embargoed until 28-Sep-2023 2:00 PM EDT Released to reporters: 26-Sep-2023 4:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 28-Sep-2023 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.



close
5.40194